↓ Skip to main content

Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells

Overview of attention for article published in Cancer Immunology, Immunotherapy, March 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
2 X users
patent
6 patents

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
53 Mendeley
Title
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells
Published in
Cancer Immunology, Immunotherapy, March 2016
DOI 10.1007/s00262-016-1816-7
Pubmed ID
Authors

Susan P. Foy, Stefanie J. Mandl, Tracy dela Cruz, Joseph J. Cote, Evan J. Gordon, Erica Trent, Alain Delcayre, James Breitmeyer, Alex Franzusoff, Ryan B. Rountree

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 23%
Student > Ph. D. Student 11 21%
Researcher 8 15%
Other 5 9%
Student > Master 3 6%
Other 5 9%
Unknown 9 17%
Readers by discipline Count As %
Medicine and Dentistry 13 25%
Agricultural and Biological Sciences 9 17%
Immunology and Microbiology 7 13%
Biochemistry, Genetics and Molecular Biology 6 11%
Neuroscience 2 4%
Other 3 6%
Unknown 13 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#3,677,373
of 26,017,215 outputs
Outputs from Cancer Immunology, Immunotherapy
#264
of 3,029 outputs
Outputs of similar age
#55,301
of 318,568 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#8
of 39 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,568 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.